SCHEMBL22388762

SCHEMBL22388762

C=C1C(=O)O[C@H]2[C@H]1CCC(C)=C1[C@H](O)C[C@@](C)(O)[C@@H]12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 7/20 0.63
▸ NLRP3 Q96P20 2/20 0.63
▸ CYP19A1 P11511 3/20 0.53
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ TP53 P04637 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ NFKB1 P19838 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ STAT6 P42226 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ THPO P40225 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Moroccolide A SCHEMBL31238194 0.79 CYP19A1 (0.60) PKMNLRP3CYP19A1ALDH1A1LMNA
Micheliolide SCHEMBL22354429 0.78 PKM (1.00) PKMNLRP3CYP19A1ALDH1A1LMNA
Micheliolide SCHEMBL18334099 0.78 PKM (1.00) PKMNLRP3CYP19A1ALDH1A1LMNA
Micheliolide SCHEMBL22375104 0.78 PKM (1.00) PKMNLRP3CYP19A1ALDH1A1LMNA
Ludartin SCHEMBL29556149 0.69 CYP19A1 (1.00) PKMNLRP3CYP19A1ALDH1A1LMNA
SCHEMBL22354262 0.68 PKM (0.56) PKMNLRP3CYP19A1ALDH1A1LMNA
SCHEMBL31006726 0.68 PKM (0.53) PKMNLRP3CYP19A1ALDH1A1LMNA
SCHEMBL24982735 0.68 PKM (0.69) PKMNLRP3CYP19A1ALDH1A1LMNA
SCHEMBL22388761 0.68 PKM (0.72) PKMNLRP3CYP19A1ALDH1A1LMNA
SCHEMBL22388763 0.68 PKM (0.72) PKMNLRP3CYP19A1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200277270-A1 MICHELIOLIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR USE AS ANTICANCER AND ANTIINFLAMMATORY AGENTS UNIVERSITY OF ROCHESTER 2020-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200277270-A1 MICHELIOLIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR USE AS ANTICANCER AND ANTIINFLAMMATORY AGENTS TNF, C9, CYP51A1 PKM 3406/4885NLRP3 95/4885CYP19A1 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback